NCT03130907

The Role of Ureteral Stenting Following Uncomplicated Ureteroscopy for Ureteral and Renal Stones: A Randomized, Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 72 (actual)
• Sponsor: San Antonio Uniformed Services Health Education Consortium · Federal
• Sex: All
• Age: 18 Years – 89 Years
• Healthy volunteers: Accepted

Summary

It is well established that uncomplicated distal ureteroscopy can be safely performed without leaving a ureteral stent. However, many urologists continue to leave ureteral stents following uncomplicated ureteroscopy, regardless of stone location, due to concerns for post-operative complications, patient symptoms and to reduce unplanned medical visits. There is a paucity of data regarding the utility of stent placement for proximal ureteral or renal stones following ureteroscopy. We have designed a prospective, randomized controlled trial to evaluate the role of ureteral stent placement following ureteroscopy and pyeloscopy in proximal and renal stones.

Conditions

• Ureteroscopy

Interventions

Type	Name	Description
DEVICE	Placement of ureteral stent	will randomize groups to either receive a postoperative ureteral stent or not.

Timeline

• Start date: 2017-06-01
• Primary completion: 2020-04-01
• Completion: 2020-05-16
• First posted: 2017-04-27
• Last updated: 2020-06-02

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study